A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy

Clinical trial NCT05405361 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05405361
Sponsor: argenx
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multifocal Motor Neuropathy (MMN)

Start date: 2023-01-18
Primary completion: 2029-09-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.